LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • Should you invest £1,000 in Vodafone right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Vodafone made the list?

    See the 6 stocks

  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Articles

    £10,000 invested in the FTSE 100 at the start of the year is now worth…

    The FTSE 100's often incorrectly seen as a barometer for the UK economy. Donald Trump’s tariffs have demonstrated that it’s…

    Read more »

    Long-term vs short-term investing concept on a staircase
    Investing Articles

    Down 28% in 8 months, is AstraZeneca’s share price too cheap for me to pass up right now?

    AstraZeneca’s share price has fallen a long way from its September high, but this may mean an opportunity for me…

    Read more »

    artificial intelligence investing algorithms
    Investing Articles

    Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI

    With the start of a new tax year, Zaven Boyrazian uses ChatGPT to build a Stocks and Shares ISA starter…

    Read more »

    Investing Articles

    I asked ChatGPT where the FTSE 100 will be in 6 months: here’s what it said…

    Let’s be realistic, ChatGPT can’t predict the future. But it did do a good job of compiling data from brokerages…

    Read more »

    Investing Articles

    These FTSE shares may offer some safety as Trump slaps tariffs on trading partners

    FTSE shares moved lower on 3 April, after US President Donald Trump introduced hefty tariffs on its trading partners. These…

    Read more »

    Investing Articles

    3 top FTSE 100 shares to consider for a new ISA

    The FTSE 100 is packed with top-notch companies that can form the building blocks of a quality Stocks and Shares…

    Read more »

    Surprised Black girl holding teddy bear toy on Christmas
    Investing Articles

    A £10,000 investment in AstraZeneca shares last Christmas is now worth…

    AstraZeneca shares have enjoyed moderate gains this year, helping to recover some of last year’s losses. But does it remain…

    Read more »

    Engineer Project Manager Talks With Scientist working on Computer
    Investing Articles

    Prediction: 12 months from now, AstraZeneca’s share price could be…

    AstraZeneca is making a $1bn investment for the long term, but what lies in store for investors over the next…

    Read more »

    Investing Articles

    £10,000 invested in AstraZeneca shares 1 year ago is now worth…

    AstraZeneca shares have recovered from their brief slump with investors broadly buoyed by the company’s long-term business prospects.

    Read more »

    Investing Articles

    I asked ChatGPT to name 5 UK stocks for a perfectly balanced ISA – here’s what it picked! 

    Harvey Jones is looking for UK stocks to add to this year's ISA, and decided to call in some assistance…

    Read more »

    Investing Articles

    Down 13% from its year high at £116.50 now, AstraZeneca’s share price looks cheap to me anywhere under £219.81

    AstraZeneca’s share price has dropped recently on concerns relating to its Chinese operation, but this may have left the shares…

    Read more »

    The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
    Dividend Shares

    2 retirement shares that long-term investors should consider for steady income

    Ken Hall takes a look at two big-name retirement shares in the FTSE 100 with market-leading positions and track records…

    Read more »